Therapy News and Research

RSS
Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

Study investigates prognostic indicators for BCa patients treated with RC

Study investigates prognostic indicators for BCa patients treated with RC

Mesenchymal stem cells safe, effective for treating poor graft function: Study

Mesenchymal stem cells safe, effective for treating poor graft function: Study

R-Tech Ueno enrolls retinitis pigmentosa patients in Phase 3 clinical study of UF-021 ophthalmic solution

R-Tech Ueno enrolls retinitis pigmentosa patients in Phase 3 clinical study of UF-021 ophthalmic solution

Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

Umbilical cord blood stem cell transplants may be an effective alternative to treat Hurler's syndrome

Umbilical cord blood stem cell transplants may be an effective alternative to treat Hurler's syndrome

New molecular sensor technique for cancer therapy detects lactate levels in individual cells

New molecular sensor technique for cancer therapy detects lactate levels in individual cells

Abiraterone's anti-androgenic properties may stop tumor growth of CRPC, says prize-winning Dutch study

Abiraterone's anti-androgenic properties may stop tumor growth of CRPC, says prize-winning Dutch study

Study shows promising benefit of combination therapy in CRPC patients

Study shows promising benefit of combination therapy in CRPC patients

Surgery better than radiotherapy for treatment of localised prostate cancer

Surgery better than radiotherapy for treatment of localised prostate cancer

Small percentage of adults who receive rapid HIV treatment following infection might achieve 'functional cure,' French researchers say

Small percentage of adults who receive rapid HIV treatment following infection might achieve 'functional cure,' French researchers say

Research roundup: Nurse education and post-surgery mortality; The influence of publicly reported quality-of-care measures

Research roundup: Nurse education and post-surgery mortality; The influence of publicly reported quality-of-care measures

Study examines mindfulness in large group of adolescents in school-based setting

Study examines mindfulness in large group of adolescents in school-based setting

Interventional endovascular therapy is safe but does not improve MS outcomes: Study

Interventional endovascular therapy is safe but does not improve MS outcomes: Study

Monitoring, treating kidney disease patients with blood pressure fluctuations may improve health: Study

Monitoring, treating kidney disease patients with blood pressure fluctuations may improve health: Study

Researchers receive AHRF grant to investigate genetic hearing screening program for newborns

Researchers receive AHRF grant to investigate genetic hearing screening program for newborns

Pervasive myths surround clinical trials

Pervasive myths surround clinical trials

Researchers find no overall recovery benefit to patients treated with clot-removal devices

Researchers find no overall recovery benefit to patients treated with clot-removal devices

Researchers to develop miniature chips to treat cancer tumours

Researchers to develop miniature chips to treat cancer tumours

Probiotics help stress-associated gastrointestinal disorders, study says

Probiotics help stress-associated gastrointestinal disorders, study says

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.